Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France

Noémie Roland; Jerôme Drouin; David Desplas; François Cuenot; Rosemary Dray-Spira; Alain Weill; Mahmoud Zureik

doi:10.1097/AOG.0000000000004281

Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France

Obstet Gynecol. 2021 Mar 1;137(3):415-417. doi: 10.1097/AOG.0000000000004281.

Authors

Noémie Roland¹, Jerôme Drouin, David Desplas, François Cuenot, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik

Affiliation

¹ EPI-PHARE, a scientific cooperation between The French National Health Insurance Fund (CNAM) and the French National Agency for Medicines and Health Products Safety (ANSM).

Abstract

Hormonal medication dispensations decreased substantially during lockdown and after in France, especially for emergency contraception, levonorgestrel-releasing intrauterine devices, and ovulation inductors.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Communicable Disease Control / methods*
Contraception / statistics & numerical data*
Female
France
Humans
Insurance Claim Review
Ovulation Induction / statistics & numerical data*